ARTICLE | Company News
Human Genome Sciences, GlaxoSmithKline deal
May 21, 2012 7:00 AM UTC
Human Genome said its board unanimously recommended shareholders reject the hostile tender offer from GlaxoSmithKline to acquire the biotech for $13 per share. Human Genome also adopted a shareholder ...